Citius Oncology (CTOR) Cash from Financing Activities (2023 - 2026)

Citius Oncology's Cash from Financing Activities history runs 4 years deep, the most recent figure standing at -$231199.0 for Q1 2026.

• In Q1 2026, Cash from Financing Activities changed N/A year-over-year to -$231199.0; the TTM figure through Mar 2026 stood at -$9.4 million (changed N/A YoY), while the FY2025 annual figure was $15.2 million, up 211.19% from the prior year.
• Cash from Financing Activities was -$231199.0 for Q1 2026 at Citius Oncology, down from $15.1 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $15.1 million in Q4 2025 to a low of -$24.5 million in Q1 2024.
• Historically, Cash from Financing Activities has averaged -$1.7 million across 4 years, with a median of $264393.0 in 2024.